BREAKING NEWS

Pfizer begins testing pneumococcal vaccine along with COVID booster shot

By REUTERS

MAY 24, 2021 14:19

Pfizer Inc said on Monday it has started immunizing the first patients in a new study looking at administering the company's 20-valent pneumococcal conjugate vaccine candidate following a booster dose of the Pfizer-BioNTech COVID-19 shot.

The study will include 600 adults over 65 years who will be recruited from the late-stage study of the Pfizer-BioNTech COVID-19 vaccine, and will have received their second dose of the vaccine at least six months prior to entering the co-administration study, the company said.

Hostage Forum urges deal after probe into murder of six hostages

By JERUSALEM POST STAFF

12/24/2024 09:15 PM

IAF strikes Hamas launch site embedded near UN compound in Gaza

By JERUSALEM POST STAFF

12/24/2024 08:45 PM

Israel completes investigation on Yemen missile incident in Jaffa

By JERUSALEM POST STAFF

12/24/2024 08:32 PM

PMO announces return of Israeli hostage deal negotiation team from Qatar

By JERUSALEM POST STAFF

12/24/2024 08:32 PM